|
|
41
|
5281BY
|
T-MYCIN 0.3% EYE DR (ARP) TOBRAMYCI (BH)
|
5ML
|
BH
|
5.4366
|
0.3%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
5281CB
|
TOBREX 0.3% EYE DR (NVS/COL) TOBRAMYCIN
|
5ML
|
C
|
23.30
|
0.3%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
5281CB
|
TOBREX 0.3% EYE DR (NVS) TOBRAMYCIN (C)
|
5ML
|
C
|
16.3099
|
0.3%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
5281P
|
GOTABIOTIC 0.3% EYE DR (LPO/COL) TOBRAMY
|
5ML
|
BH
|
7.34
|
0.3%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
5281P
|
GOTABIOTIC 0.3% EYE DR (LPO) TOBRAMYCIN (BH)
|
5ML
|
BH
|
7.421
|
0.3%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
5282F
|
T-MYCIN 0.3% OINT (ARP/AHI) TOBRAMYCIN
|
3G
|
BH
|
10.00
|
0.3%
|
0
|
2022-04-01
|
2022-09-30
|
|
|
|
0
|
|
|
41
|
5282F
|
T-MYCIN 0.3% OINT (ARP) TOBRAMYCIN (BH)
|
3G
|
BH
|
5.3823
|
0.3%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
5282G
|
TOBREX 0.3% EYE OINT (NVS/COL) TOBRAMYCIN
|
3.5G
|
BH
|
15.49
|
0.3%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
5282G
|
TOBREX 0.3% EYE OINT (NVS) TOBRAMYC (C)
|
3.5G
|
C
|
15.4944
|
0.3%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|